Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 11, 2015Cancer DiscoveryOpen Access

Co-occurring Genomic Alterations Define Major Subsets of KRAS -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

View Full Paper
Ask AI
Bookmark
Share

Authors

FSFerdinandos SkoulidisThe University of Texas MD Anderson Cancer CenterLBLauren A. ByersThe University of Texas MD Anderson Cancer CenterLDLixia DiaoThe University of Texas MD Anderson Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Skoulidis et al. (2015) studied this question.

synapsesocial.com/papers/69d80ec645af6083e6ae2c32https://doi.org/10.1158/2159-8290.cd-14-1236
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1ER stress–mediated autophagy promotes Myc-dependent transformation and tumor growth2012 · 459 citations
  2. 2An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance2012 · 1,144 citations
  3. 3Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication2011 · 277 citations
  4. 4MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors2010 · 374 citations
  5. 5K + Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension2011 · 1,008 citations